Predicting prognosis and immunotherapy response in colorectal cancer by pericytes insights from single-cell RNA sequencing
Human Molecular Genetics · 2024
DOI: 10.1093/hmg/ddae064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2024. Verfasst von Chen Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, University of Chinese Academy of Sciences, Yuquan Road, Shijingshan District, Beijing 100049, China. Hauptthemen laut MEDLINE: Pericytes, Colorectal Neoplasms, Single-Cell Analysis, Immunotherapy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: National Key R&D Program of China.
Abstract (Originalsprache)
Immunotherapy has revolutionized the treatment of tumors, but there are still a large number of patients who do not benefit from immunotherapy. Pericytes play an important role in remodeling the immune microenvironment. However, how pericytes affect the prognosis and treatment resistance of tumors is still unknown. This study jointly analyzed single-cell RNA sequencing (scRNA-seq) data and bulk RNA sequencing data of multiple cancers to reveal pericyte function in the colorectal cancer microenvironment. Analyzing over 800 000 cells, it was found that colorectal cancer had more pericyte enrichment in tumor tissues than other cancers. We then combined the TCGA database with multiple public datasets and enrolled more than 1000 samples, finding that pericyte may be closely related to poor prognosis due to the higher epithelial-mesenchymal transition (EMT) and hypoxic characteristics. At the same time, patients with more pericytes have higher immune checkpoint molecule expressions and lower immune cell infiltration. Finally, the contributions of pericyte in poor treatment response have been demonstrated in multiple immunotherapy datasets (n = 453). All of these observations suggest that pericyte can be used as a potential biomarker to predict patient disease progression and immunotherapy response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, University of Chinese Academy of Sciences, Yuquan Road, Shijingshan District, Beijing 100049, China.
- BGI Research, Beishan Industrial Zone, Yantian District, Shenzhen 518083, China.
ORCID-Profile: Guibo Li
Förderung
- National Key R&D Program of China
Zitieren
APA
Wei, C., Wang, W., Hu, Z., Huang, Z., Lu, Y., Zhou, W., Liu, X., Jin, X., Yin, J., & Li, G. (2024). Predicting prognosis and immunotherapy response in colorectal cancer by pericytes insights from single-cell RNA sequencing. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddae064
Vancouver
Wei C, Wang W, Hu Z, Huang Z, Lu Y, Zhou W, et al. Predicting prognosis and immunotherapy response in colorectal cancer by pericytes insights from single-cell RNA sequencing. Human Molecular Genetics. 2024. doi:10.1093/hmg/ddae064
BibTeX
@article{Wei2024,
author = {Wei, Chen and Wang, Weikai and Hu, Zhihao and Huang, Zhuoli and Lu, Ye and Zhou, Wenwen and Liu, Xiaoying and Jin, Xin and Yin, Jianhua and Li, Guibo},
title = {Predicting prognosis and immunotherapy response in colorectal cancer by pericytes insights from single-cell RNA sequencing},
journal = {Human Molecular Genetics},
year = {2024},
doi = {10.1093/hmg/ddae064}
}
EUVIMED